Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | MMP2 | P08253 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | GMNN | O75496 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | MMP9 | P14780 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | MMP8 | P22894 | 1/20 | 0.58 |
| ▸ | CCR1 | P32246 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13337941 | 0.96 | MEN1 (0.56) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL2939028 | 0.87 | MEN1 (0.58) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL341142 | 0.86 | SLC40A1 (0.62) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL27928520 | 0.85 | KMT2A (0.66) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL2283401 | 0.83 | KDR (0.56) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL2286768 | 0.83 | TDP1 (0.52) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL31130165 | 0.83 | CYP3A4 (0.61) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL7774451 | 0.83 | CYP3A4 (0.61) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL17749155 | 0.83 | GLO1 (0.56) | GLO1ALOX15HTTCYP3A4CYP1A2 | |
| SCHEMBL4546341 | 0.83 | TDP1 (0.62) | GLO1ALOX15HTTCYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090227626-A1 | NOVEL POLYQUINOLINE DERIVATIVES AND THERAPEUTIC USE THEREOF | PALUMED S.A. (FR) | 2009-09-10 | — | — | US | claimed |
| EP-1919894-A2 | NOVEL POLYQUINOLINE DERIVATIVES AND THE THERAPEUTIC USE THEREOF | Palumed SA (FR) | 2008-05-14 | — | — | EP | claimed |
| WO-2007015017-A2 | NOVEL POLYQUINOLINE DERIVATIVES AND THE THERAPEUTIC USE THEREOF | PALUMED S.A. (FR) | 2007-02-08 | — | — | WO | claimed |
| EP-3549960-B1 | PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-03-24 | — | — | EP | disclosed |
| EP-3549960-B1 | PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-03-24 | — | — | EP | disclosed |
| EP-3549960-A1 | PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR | Dow Global Technologies Llc (US) | 2019-10-09 | — | — | EP | disclosed |
| EP-2536770-B1 | PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-06-05 | — | — | EP | disclosed |
| EP-2536770-B1 | PROCESS FOR POLYMERIZING AN OLEFIN MONOMER AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-06-05 | — | — | EP | disclosed |
| US-10184052-B2 | Near infrared radiation-absorbing composition, near infrared radiation cut-off filter and production method therefor, and camera module and production method therefor | FUJIFILM CORPORATION (JP) | 2019-01-22 | — | — | US | disclosed |
| US-20180094086-A1 | NEAR INFRARED ABSORBING COMPOSITION, NEAR INFRARED CUT FILTER, METHOD OF MANUFACTURING NEAR INFRARED CUT FILTER, DEVICE, METHOD OF MANUFACTURING COPPER-CONTAINING POLYMER, AND COPPER-CONTAINING POLYMER | FUJIFILM CORPORATION (JP) | 2018-04-05 | — | — | US | disclosed |
| US-20180094086-A1 | NEAR INFRARED ABSORBING COMPOSITION, NEAR INFRARED CUT FILTER, METHOD OF MANUFACTURING NEAR INFRARED CUT FILTER, DEVICE, METHOD OF MANUFACTURING COPPER-CONTAINING POLYMER, AND COPPER-CONTAINING POLYMER | FUJIFILM CORPORATION (JP) | 2018-04-05 | — | — | US | disclosed |
| US-20090227626-A1 | NOVEL POLYQUINOLINE DERIVATIVES AND THERAPEUTIC USE THEREOF | PALUMED S.A. (FR) | 2009-09-10 | — | — | US | disclosed |
| EP-1919894-A2 | NOVEL POLYQUINOLINE DERIVATIVES AND THE THERAPEUTIC USE THEREOF | Palumed SA (FR) | 2008-05-14 | — | — | EP | disclosed |
| US-7285518-B2 | Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions | CHEVRON ORONITE COMPANY LLC (US) | 2007-10-23 | — | — | US | disclosed |
| EP-1801105-A1 | Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions | Chevron Oronite Company LLC (US) | 2007-06-27 | — | — | EP | disclosed |
| US-20070142245-A1 | Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions | CHEVRON ORONITE COMPANY LLC | 2007-06-21 | — | — | US | disclosed |
| WO-2007015017-A2 | NOVEL POLYQUINOLINE DERIVATIVES AND THE THERAPEUTIC USE THEREOF | PALUMED S.A. (FR) | 2007-02-08 | — | — | WO | disclosed |
| US-6939969-B2 | Tri-and bidentate amido ligands prepared by palladium0 coupling and metallation thereof to form metal-amido catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-09-06 | — | — | US | disclosed |
| US-20030032808-A1 | Tri-and bidentate amido ligands prepared by palladium0 coupling and metallation threreof to form metal-amido catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2003-02-13 | — | — | US | disclosed |
| WO-2002079207-A2 | TRI-AND BIDENTATE AMIDO LIGANDS PREPARED BY PALLADIUM0 COUPLING AND METALLATION THEREOF TO FORM METAL-AMIDO CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032808-A1 | Tri-and bidentate amido ligands prepared by palladium0 coupling and metallation threreof to form metal-amido catalysts | PUF60, PDCD10, HDAC10 | GLO1 4360/4885ALOX15 3713/4885HTT 2578/4885 |
| US-20070142245-A1 | Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions | ALOX12, ALOX15B, HRH1 | GLO1 2785/4885ALOX15 6/4885HTT 78/4885 |
| US-20090227626-A1 | NOVEL POLYQUINOLINE DERIVATIVES AND THERAPEUTIC USE THEREOF | HTT, UBQLN2, UBQLN1 | GLO1 1189/4885ALOX15 2801/4885HTT 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.